INTRAMUSCULAR HUMAN INTERFERON-β INJECTIONS IN TREATMENT OF CONDYLOMATA ACUMINATA
1984; Elsevier BV; Volume: 323; Issue: 8385 Linguagem: Inglês
10.1016/s0140-6736(84)91450-8
ISSN1474-547X
AutoresAlexander Schonfeld, Amihai Schattner, Madeleine Crespi, Hanoch Levavi, J. Shoham, Schmuel Nitke, David Wallach, Talia Hahn, Ovadia Yarden, Thomas Doerner, Michet Revel,
Tópico(s)Natural product bioactivities and synthesis
ResumoA two-part study was done to assess the value of human fibroblast interferon (IFN-β) in the treatment of condylomata acuminata. The first part was an open study of different IFN-β preparations, which showed that intramuscular injection was the most suitable mode of administration of IFN-β. In the double-blind placebo section 22 patients were given injections of 2×106 units IFN-β or placebo for 10 consecutive days and followed up for 3 months. In 9 of the 11 in the IFN-β group and 2 in the placebo group lesions disappeared from about 5 weeks after completion of the course of injections. After 3 months 8 of the non-responders were given a course of IFN-β and all responded to treatment. None of those who had responded has had a recurrence, the disease-free period now being 12 months. Changes in (2'-5') oligo A synthetase levels in white blood cells confirm that intramuscular injections of IFN-β produce a systemic response.
Referência(s)